A. Study population | ||
Overdose | Other consciousness disorders | |
n = 128 | n = 94 | |
Age (Average ± S.D.) | 40.6 ± 18.4 | 51.9 ± 19.7 |
≤ 39 years | 72 | 28 |
40–59 years | 34 | 31 |
≥ 60 years | 22 | 35 |
Female/Male (n) | 95/33 | 34/60 |
≤ 39 years | 56/16 | 5/23 |
40–59 years | 24/10 | 11/20 |
≥ 60 years | 15/7 | 18/17 |
Medical historya | ||
Medical department (n, [%]) | ||
Psychiatry | 68 [53.1] | 14 [14.9] |
Psychiatry and general medical department | 29 [22.7] | 10 [10.6] |
(Psychiatry positive) | (97 [75.8]) | (24 [25.5]) |
General medical department | 20 [15.6] | 51 [54.3] |
None or unclear | 11 [8.6] | 19 [20.2] |
Psychiatric disorders (n, [%]) | ||
ICD-10 | ||
F2 (Schizophrenia, schizotypal, and delusional disorders) | 25 [19.5] | 8 [8.5] |
F3 (Mood [affective] disorders) | 60 [46.9] | 12 [12.8] |
F4 (Neurotic, stress-related and somatoform disorders) | 31 [24.2] | 3 [3.2] |
F5 (Behavioural syndromes associated with physiological disturbances and physical factors) | 10 [7.8] | 1 [1.1] |
F6 (Disorders of adult personality and behaviour) | 9 [7.0] | 1 [1.1] |
Others | 20 [15.6] | 4 [4.3] |
Other disorders (n, [%]) | ||
Cardiovascular disorder | 17 [13.3] | 17 [18.1] |
Respiratory disorder | 9 [7.0] | 4 [4.3] |
Other disorders | 78 [60.9] | 57 [60.6] |
Unclear | 9 [7.0] | 3 [3.2] |
None | 3 [2.3] | 15 [16.0] |
Outcome (n, [%]) | ||
Hospital discharge | 107 [83.6] | 57 [60.6] |
Hospitalization | 17 [13.3] | 29 [30.9] |
Death | 0 [0] | 7 [7.4] |
Unclear | 4 [3.1] | 1 [1.1] |
B. Prescribed drugs | ||
Overdose | Other consciousness disorders | |
Psychotropic drugs (n) | 87 | 32 |
Benzodiazepines (n, [%]) | 71 [55.5] | 27 [27.6] |
Antidepressants (n, [%]) | 40 [31.3] | 10 [10.2] |
Antipsychotics (n, [%]) | 54 [42.2] | 17 [17.3] |
Anticonvulsants (n, [%]) | 29 [22.7] | 6 [6.1] |
Lithium carbonate (n, [%]) | 13 [10.2] | 1 [1.02] |